Eric Crombez, EVP and Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 344 shares at $24.96 ($9K) on 2026-05-05, disclosed to the SEC on 2026-05-06.
Seasonal sale ($9k) by EVP and Chief Medical Officer — this insider has traded RARE in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| ABEO | SELL | 2026-02-02 | $166K | — | Filing → |
| ABEO | SELL | 2025-08-15 | $33K | — | Filing → |
| RARE | SELL | 2025-05-05 | $29K | — | Filing → |